Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of ...

Click in for more news from The Hill{beacon} Healthcare Healthcare  The Big Story Trump’s FDA nominee draws mixed reception President Trump on Wednesday announced Dr. Heidi ...

A promising new mRNA based-vaccine combined with an immunotherapy drug could prevent melanoma from returning in patients. The ...

By Sinéad Carew and Avinash P Aug 19 (Reuters) - The main U.S. stock market indexes closed modestly higher on Wednesday, as ...

It’s very exciting,” a melanoma expert said of the experimental cancer vaccine announced by pharmaceutical companies Moderna ...

Moderna and Merck said on Wednesday (August 19) that a personalized mRNA cancer vaccine reduced the risk of recurrence and ...

A new study from researchers at the Texas A&M College of Veterinary Medicine and Biomedical Sciences (VMBS) has uncovered a ...

Merck and Moderna say the experimental treatment extended the time before skin cancer returned in patients at high risk.

Can Trump still impose new tariffs? He can. Earlier this year, the Supreme Court struck down Trump's use of a specific law, ...

Merck and Moderna have announced that a new mRNA vaccine has succeeded in blocking the return of one of the deadliest cancers ...

A personalized mRNA cancer vaccine from Moderna and Merck is showing promising results in a late-stage melanoma trial, ...

Moderna and Merck's mRNA cancer vaccine marks a breakthrough in personalized oncology, with broad financial implications for ...